Bahrain announced that it had approved the emergency use of the Pfizer-BioNTech coronavirus vaccine, becoming the second country after the United Kingdom to give a green light to the drug.
On Friday, Bahrain announced that it had approved the emergency use of the Pfizer-BioNTech coronavirus vaccine, becoming the second country after the United Kingdom to give a green light to the drug.
According to a statement carried by the official Bahrain News Agency (BNA), Mariam al-Jalahma, CEO of the National Health Regulatory Authority said: “The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom’s national Covid-19 response.”
However, the exact timing for the rollout of the vaccine was not specified. The vaccine is produced by US pharmaceuticals giant Pfizer and its German partner BioNTech.
On Wednesday,Boris Johnson-led Britain became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for use and informed that it will be rolled out from early next week.
“The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use,” the UK government said.
“The vaccine will be made available across the UK from next week.”
Britain’s emergency use authorization, Pfizer said, marks a historic moment in the fight against COVID-19.
“This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.,” said Albert Bourla, the CEO of Pfizer.